iPSCs derived from esophageal atresia patients reveal SOX2 dysregulation at the anterior foregut stage.


Journal

Disease models & mechanisms
ISSN: 1754-8411
Titre abrégé: Dis Model Mech
Pays: England
ID NLM: 101483332

Informations de publication

Date de publication:
01 11 2022
Historique:
received: 03 03 2022
accepted: 18 10 2022
pubmed: 2 11 2022
medline: 30 11 2022
entrez: 1 11 2022
Statut: ppublish

Résumé

A series of well-regulated cellular and molecular events result in the compartmentalization of the anterior foregut into the esophagus and trachea. Disruption of the compartmentalization process leads to esophageal atresia/tracheoesophageal fistula (EA/TEF). The cause of EA/TEF remains largely unknown. Therefore, to mimic the early development of the esophagus and trachea, we differentiated induced pluripotent stem cells (iPSCs) from EA/TEF patients, and iPSCs and embryonic stem cells from healthy individuals into mature three-dimensional esophageal organoids. CXCR4, SOX17 and GATA4 expression was similar in both patient-derived and healthy endodermal cells. The expression of the key transcription factor SOX2 was significantly lower in the patient-derived anterior foregut. We also observed an abnormal expression of NKX2.1 (or NKX2-1) in the patient-derived mature esophageal organoids. At the anterior foregut stage, RNA sequencing revealed the critical genes GSTM1 and RAB37 to be significantly lower in the patient-derived anterior foregut. We therefore hypothesize that a transient dysregulation of SOX2 and the abnormal expression of NKX2.1 in patient-derived cells could be responsible for the abnormal foregut compartmentalization.

Identifiants

pubmed: 36317486
pii: 283171
doi: 10.1242/dmm.049541
pmc: PMC10655818
pii:
doi:

Substances chimiques

SOX2 protein, human 0
SOXB1 Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : PJT-156408
Pays : Canada
Organisme : CIHR
ID : PJT-174993
Pays : Canada

Informations de copyright

© 2022. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Références

Nat Rev Dis Primers. 2019 Apr 18;5(1):26
pubmed: 31000707
Methods. 2016 May 15;101:73-84
pubmed: 26404920
Dev Dyn. 2007 Mar;236(3):746-54
pubmed: 17260385
Cell Stem Cell. 2018 Oct 4;23(4):516-529.e5
pubmed: 30244870
Dev Biol. 1999 May 1;209(1):60-71
pubmed: 10208743
Stem Cells. 2014 Jan;32(1):126-34
pubmed: 24105929
J Clin Invest. 2017 Jun 1;127(6):2378-2391
pubmed: 28481227
Nat Biotechnol. 2014 Jan;32(1):84-91
pubmed: 24291815
J Biol Chem. 2001 Apr 20;276(16):12749-55
pubmed: 11278289
J Clin Invest. 2010 Mar;120(3):840-9
pubmed: 20197623
Dev Dyn. 2015 Mar;244(3):277-88
pubmed: 25329576
Cell Rep. 2014 Oct 23;9(2):701-11
pubmed: 25373907
Annu Rev Cell Dev Biol. 1999;15:393-410
pubmed: 10611967
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Eur J Hum Genet. 2021 Jan;29(1):122-130
pubmed: 32641753
Cell Death Dis. 2018 Aug 29;9(9):868
pubmed: 30158579
Nature. 1990 Feb 15;343(6259):617-22
pubmed: 2154694
Genome Biol. 2014;15(12):550
pubmed: 25516281
Physiol Rev. 2019 Jan 1;99(1):79-114
pubmed: 30328784
Am Fam Physician. 1999 Feb 15;59(4):910-6, 919-20
pubmed: 10068713
Elife. 2020 Jun 09;9:
pubmed: 32515350
Nat Protoc. 2015 Mar;10(3):413-25
pubmed: 25654758
Eur J Med Genet. 2009 Sep-Oct;52(5):287-90
pubmed: 19410022
Stem Cells. 2017 Apr;35(4):1106-1119
pubmed: 28142228
Nat Commun. 2020 Aug 27;11(1):4158
pubmed: 32855417
Nat Genet. 2020 Jan;52(1):40-47
pubmed: 31844321
Hum Mol Genet. 2017 Aug 15;26(16):3031-3045
pubmed: 28521042
Dev Biol. 2021 Sep;477:85-97
pubmed: 34023332
Genome Biol. 2019 Dec 16;20(1):278
pubmed: 31842956
Development. 2007 Jul;134(13):2521-31
pubmed: 17522155
F1000Res. 2020 Apr 28;9:304
pubmed: 32489650
Stem Cell Investig. 2016 Dec 08;3:88
pubmed: 28078268
Cell Stem Cell. 2020 Oct 1;27(4):574-589.e8
pubmed: 32810435
Dev Biol. 2010 Jan 15;337(2):351-62
pubmed: 19913007
Biol Open. 2020 Feb 7;9(2):
pubmed: 31988094
Nucleic Acids Res. 2019 Jan 8;47(D1):D766-D773
pubmed: 30357393
Differentiation. 2006 Sep;74(7):422-37
pubmed: 16916379
Differentiation. 2016 Dec;92(5):281-290
pubmed: 27087651
Dev Cell. 2019 Dec 16;51(6):675-683.e4
pubmed: 31813798
Nat Commun. 2022 May 26;13(1):2965
pubmed: 35618699
Am J Physiol Gastrointest Liver Physiol. 2015 Aug 15;309(4):G216-28
pubmed: 26138464
Wiley Interdiscip Rev Dev Biol. 2012 Mar-Apr;1(2):184-202
pubmed: 23801435
Birth Defects Res A Clin Mol Teratol. 2010 Sep;88(9):743-7
pubmed: 20740495
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Development. 2011 Mar;138(5):971-81
pubmed: 21303850
Nat Rev Genet. 2019 Jul;20(7):377-388
pubmed: 30737492
Cell Stem Cell. 2018 Oct 4;23(4):501-515.e7
pubmed: 30244869
Stem Cells Dev. 2020 Aug 1;29(15):953-966
pubmed: 32515280
Eur J Med Genet. 2014 Aug;57(8):440-52
pubmed: 24931924
PLoS One. 2011;6(7):e22493
pubmed: 21799872
Stem Cell Res. 2022 Apr;60:102711
pubmed: 35193008
Dev Cell. 2019 Dec 16;51(6):665-674.e6
pubmed: 31813796

Auteurs

Suleen Raad (S)

Esophageal Development and Engineering Laboratory, CHU Sainte-Justine Research Center, 3175 Côte Sainte-Catherine, Montréal, Quebec H3T 1C5, Canada.

Anu David (A)

Esophageal Development and Engineering Laboratory, CHU Sainte-Justine Research Center, 3175 Côte Sainte-Catherine, Montréal, Quebec H3T 1C5, Canada.

Melanie Sagniez (M)

CHU Sainte-Justine Research Center, 3175 Côte Sainte-Catherine, Montréal, Quebec H3T 1C5, Canada.
Department of Biochemistry and Molecular Medicine, Faculty of Medicine, University of Montreal, Montréal, Quebec H3T 1J4, Canada.

Bastien Paré (B)

CHU Sainte-Justine Research Center, 3175 Côte Sainte-Catherine, Montréal, Quebec H3T 1C5, Canada.
Department of Biochemistry and Molecular Medicine, Faculty of Medicine, University of Montreal, Montréal, Quebec H3T 1J4, Canada.

Zakaria Orfi (Z)

CHU Sainte-Justine Research Center, 3175 Côte Sainte-Catherine, Montréal, Quebec H3T 1C5, Canada.

Nicolas A Dumont (NA)

CHU Sainte-Justine Research Center, 3175 Côte Sainte-Catherine, Montréal, Quebec H3T 1C5, Canada.
School of Rehabilitation, Faculty of Medicine, Université de Montréal, Montréal, Quebec H3T 1J4, Canada.

Martin A Smith (MA)

CHU Sainte-Justine Research Center, 3175 Côte Sainte-Catherine, Montréal, Quebec H3T 1C5, Canada.
Department of Biochemistry and Molecular Medicine, Faculty of Medicine, University of Montreal, Montréal, Quebec H3T 1J4, Canada.

Christophe Faure (C)

Esophageal Development and Engineering Laboratory, CHU Sainte-Justine Research Center, 3175 Côte Sainte-Catherine, Montréal, Quebec H3T 1C5, Canada.
Esophageal Atresia Clinic and Division of Pediatric Gastroenterology Hepatology and Nutrition, CHU Sainte-Justine, 3715 Côte Sainte-Catherine, Université de Montréal, Montréal, Quebec H3T1C5, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH